The idea is that all our problems are related to a lack of androgenic signaling and as @Axolotl has pointed out, there is reason to believe that the return of proper androgenic action may result in a reversal of our symptoms. This is supported by the brief honeymoon periods that some people experience during the use of anti-androgenic substances. People have described quasi miraculous recoveries on such substances, which toally makes sense in the light of the theory that is currently investigated.
Sage Therapeutics is targeting the market for depression treatments. This is a multi-billion dollar market. Of course, they are not interested in doing a trial for a small group of patients that suffer from a very rare condition that is not widely accepted and often rejected. That’s because commercial drug development is highly expensive and there is no additional benefit in including us. If they capture the market for anti-depressants they’ll make billions. Why would they waste any time on a small and irrelevant group like ours?
The fact that we as a community are so small and irrelevant is why the admins here have decided to branch out. As you may have read here already, it turns out other conditions are likely driven by a very similar or identical mechanism. Hence, it makes sense to join forces with the respective communities to make our problem bigger and more relevant. The more relevant we are, the more resources we can gather for our cause. That’s why everyone from these communties needs to support the survey and 23andme project.
Still, it is unlikely that a drug will ever be developed specifically for our condition. However, our problem is closely related to key issues in prostate cancer research. And billions are invested in prostate cancer research which may result in benefits for us.
While a drug may never be specifically developed for us, we may get lucky and profit from efforts in prostate cancer research or may have at least some therapeutic benefits from developments like Sage-217. But there are also technologies like Crispr that are fast becoming powerful yet cheap tools that may not need billions of developmental costs to be applicable to us.
@Axolotl has explained it in a different thread: